ArticleJournal of geriatric oncology2018

Do older patients with non-small cell lung cancer also benefit from first-line platinum-based doublet chemotherapy? Observations from a pooled analysis of 730 prospectively-treated patients (Alliance Study A151622).

Josephine L Feliciano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.